AI assistant
Sending…
Humacyte, Inc. — Director's Dealing 2022
Jun 13, 2022
33410_dirs_2022-06-13_3f7c59e3-d46c-4dac-8c30-f432b595a3b3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Humacyte, Inc. (HUMA)
CIK: 0001818382
Period of Report: 2022-06-09
Reporting Person: Seimetz Diane (Director)
More from Humacyte, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 24
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Mar 19
Major Shareholding Notification
2026
Jan 9
Regulatory Filings
2025
Dec 16
Regulatory Filings
2025
Dec 16
Regulatory Filings
2025
Dec 15
Regulatory Filings
2025
Dec 15